Medexus Provides Business Update on GRAFAPEX for Injection, Capital Allocation, and Investor Conference Participation Pharmaceutical Investing
Royalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026 Life Science Investing
Acadia Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 6, 2026 Life Science Investing
Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers Life Science Investing
Seegnal Inc. Receives Gold Mark from the Standards Institution of Israel, Advancing Commercialization Readiness Pharmaceutical Investing
AVITA Medical Founder Fiona Wood Honored with Lifetime Achievement Award by American Burn Association Medical Device Investing
BioSyent to Present at 2026 Bloom Burton & Co. Healthcare Investor Conference Pharmaceutical Investing
Quantum-Si Announces Two Customer Posters to be Presented at the American Association of Cancer Research Annual Meeting Life Science Investing
